ArticleEntropy (Basel, Switzerland)2026
DBCL-DFNet: Dual-Branch Contrastive Learning for Multi-Omics Dynamic Fusion.
Article in Entropy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Multimodal omics data portray biological processes across molecular layers, yet their heterogeneity and high dimensionality hinder a unified representation. Existing integrative approaches either focus on local feature interactions or adopt static fusion, often overlooking the complementary global sequential context and the dynamic relevance among omics sources. Consequently, clinically critical tasks such as accurate cancer-subtype classification and therapy selection still lack sufficient accuracy and robustness. We introduce the Dual-Branch Contrastive Learning for Multi-Omics Dynamic Fusion Network (DBCL-DFNet), a dual-branch contrastive-learning framework that simultaneously encodes local heterogeneous graphs and global omics sequences, distills key features via contrastive objectives, and employs a dynamic attention mechanism for adaptive, data-driven fusion. Benchmarked on three public cancer multi-omics datasets, DBCL-DFNet outperforms both conventional machine-learning models and state-of-the-art deep-integration methods, establishing a competitive and reliable framework for multi-omics integration and demonstrating potential for precision-oncology decision-making. From an information-theoretic perspective, the framework integrates Copula-entropy-guided feature selection with mutual-information-maximizing contrastive alignment, providing a principled foundation for robust multi-omics integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.